Economist Podcasts Harms weigh: AstraZeneca vaccine fears
Mar 17, 2021
Tim Cross, Technology editor at The Economist, delves into the AstraZeneca vaccine concerns, stressing that, despite fears of blood clots, the jab is almost certainly safe. He highlights the crucial link between public trust and vaccination efforts. Gotti Epstein, China affairs editor, examines the hostage diplomacy story involving Canada and China, sparked by the arrest of a Huawei executive. They also touch on the booming NFT market and its potential to empower digital artists in new and exciting ways.
AI Snips
Chapters
Books
Transcript
Episode notes
Correlation vs. Causation
- Regulators must distinguish between correlation and causation when evaluating vaccine side effects.
- A medical event following vaccination doesn't automatically imply causation, as underlying rates of illness exist.
Blood Clot Data Discrepancy
- Data shows similar blood clot rates in vaccinated and general populations, except for a rare brain clot in Germany and Norway.
- Britain, with higher AstraZeneca vaccination rates, hasn't observed this pattern, creating data discrepancies.
Placebo Group Side Effects
- Clinical trials showed more serious side effects in the placebo group than the vaccinated group. This highlights that illnesses can occur independently of vaccination.
